Details for New Drug Application (NDA): 088571
✉ Email this page to a colleague
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 088571
Tradename: | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
Applicant: | Hospira |
Ingredient: | epinephrine; lidocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 088571
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 088571
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 088571 | ANDA | Hospira, Inc. | 0409-1209 | 0409-1209-01 | 10 AMPULE in 1 TRAY (0409-1209-01) / 5 mL in 1 AMPULE (0409-1209-10) |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 088571 | ANDA | Hospira, Inc. | 0409-1209 | 0409-1209-05 | 400 AMPULE in 1 CASE (0409-1209-05) / 5 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/ML;1.5% | ||||
Approval Date: | Sep 13, 1985 | TE: | AP | RLD: | No |
Complete Access Available with Subscription